Search

everythinglearnresearchcommunity

for

Search:↓

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Androgen levels do not determine the type of PCOS symptoms in young females.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Dosing time affects finasteride's effectiveness and safety in rats.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.